“Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Melasma”, J of Skin, vol. 9, no. 2, p. s544, Mar. 2025, doi: 10.25251/skin.10.supp.544.